ACHE and Alzheimer disease: Increased acetylcholinesterase and decreased acetylcholine in the synaptic area, as well as oxidative stress and heightened cytotoxicity signals and levels of Aβ and free radicals, are all factors in the development of AD caused by scopolamine (Tang, 2019).